Andrew Martin

9PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Oct 10, 2025
Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials.

Andrew J Martin, Yu Yang Soon, Katrin Marie Sjoquist

|Jun 02, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse.

Yu Yang Soon, Katrin Sjoquist, Ian C Marschner

|Jun 23, 2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer.

Prunella Blinman, Andrew Martin, Michael Jefford

|Jun 05, 2020
Changes to aspects of ongoing randomised controlled trials with fixed designs.

Xanthi Coskinas, John Simes, Manjula Schou

Pageof 2

Frequent Collaborators

4 joint publications

Martin R Stockler

2 joint publications

Anthony M Joshua

2 joint publications

Ian D Davis

2 joint publications

Roslyn J Francis